Global Chronic Urticaria Medicine Market Growth 2026-2032
The global Chronic Urticaria Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Chronic Urticaria Medicine refers to the specific medications used in the management of chronic urticaria, also known as chronic hives,Mainly including Antihistamines,H2 Antagonists,Leukotriene Receptor Antagonists,Corticosteroids,Immunosuppressant and Biologics.
United States market for Chronic Urticaria Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Chronic Urticaria Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Chronic Urticaria Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Chronic Urticaria Medicine players cover Johnson & Johnson, Merck, Fresenius, 3SBIO, SPHBIO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Chronic Urticaria Medicine Industry Forecast? looks at past sales and reviews total world Chronic Urticaria Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Chronic Urticaria Medicine sales for 2026 through 2032. With Chronic Urticaria Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Urticaria Medicine industry.
This Insight Report provides a comprehensive analysis of the global Chronic Urticaria Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Urticaria Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Chronic Urticaria Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Urticaria Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Urticaria Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Urticaria Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Chronic Urticaria Medicine refers to the specific medications used in the management of chronic urticaria, also known as chronic hives,Mainly including Antihistamines,H2 Antagonists,Leukotriene Receptor Antagonists,Corticosteroids,Immunosuppressant and Biologics.
United States market for Chronic Urticaria Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Chronic Urticaria Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Chronic Urticaria Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Chronic Urticaria Medicine players cover Johnson & Johnson, Merck, Fresenius, 3SBIO, SPHBIO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Chronic Urticaria Medicine Industry Forecast? looks at past sales and reviews total world Chronic Urticaria Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Chronic Urticaria Medicine sales for 2026 through 2032. With Chronic Urticaria Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Urticaria Medicine industry.
This Insight Report provides a comprehensive analysis of the global Chronic Urticaria Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Urticaria Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Chronic Urticaria Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Urticaria Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Urticaria Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Urticaria Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Loratadine
- Desloratadine
- Fexofenadine
- Ebastine
- Stastine
- Cetirizine
- Levocetirizine
- Cinnarizine
- Other
- Hospital and Clinic
- Specialist Medical Centre
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Merck
- Fresenius
- 3SBIO
- SPHBIO
- Sun Pharmaceutical Industries
- Yangtze River Pharmaceutical Group
- CSPC Pharmaceutical Group
- Shanxi C&Y Pharmaceutical Group
- Lianhuan Pharma
- Jiudian Pharmaceutical
- What is the 10-year outlook for the global Chronic Urticaria Medicine market?
- What factors are driving Chronic Urticaria Medicine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doChronic Urticaria Medicine market opportunities vary by end market size?
- How does Chronic Urticaria Medicine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Urticaria Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Chronic Urticaria Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Chronic Urticaria Medicine by Country/Region, 2021, 2025 & 2032
2.2 Chronic Urticaria Medicine Segment by Type
2.2.1 Loratadine
2.2.2 Desloratadine
2.2.3 Fexofenadine
2.2.4 Ebastine
2.2.5 Stastine
2.2.6 Cetirizine
2.2.7 Levocetirizine
2.2.8 Cinnarizine
2.2.9 Other
2.2.10 Chronic Urticaria Medicine Sales by Type
2.2.10.1 Global Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
2.2.10.2 Global Chronic Urticaria Medicine Revenue and Market Share by Type (2021-2026)
2.2.10.3 Global Chronic Urticaria Medicine Sale Price by Type (2021-2026)
2.3 Chronic Urticaria Medicine Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Specialist Medical Centre
2.3.3 Retail Pharmacies
2.3.4 Other
2.3.5 Chronic Urticaria Medicine Sales by Application
2.3.5.1 Global Chronic Urticaria Medicine Sale Market Share by Application (2021-2026)
2.3.5.2 Global Chronic Urticaria Medicine Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Chronic Urticaria Medicine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Chronic Urticaria Medicine Breakdown Data by Company
3.1.1 Global Chronic Urticaria Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Chronic Urticaria Medicine Sales Market Share by Company (2021-2026)
3.2 Global Chronic Urticaria Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Chronic Urticaria Medicine Revenue by Company (2021-2026)
3.2.2 Global Chronic Urticaria Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Chronic Urticaria Medicine Sale Price by Company
3.4 Key Manufacturers Chronic Urticaria Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Urticaria Medicine Product Location Distribution
3.4.2 Players Chronic Urticaria Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHRONIC URTICARIA MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Chronic Urticaria Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Chronic Urticaria Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Chronic Urticaria Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Chronic Urticaria Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Chronic Urticaria Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Chronic Urticaria Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Chronic Urticaria Medicine Sales Growth
4.4 APAC Chronic Urticaria Medicine Sales Growth
4.5 Europe Chronic Urticaria Medicine Sales Growth
4.6 Middle East & Africa Chronic Urticaria Medicine Sales Growth
5 AMERICAS
5.1 Americas Chronic Urticaria Medicine Sales by Country
5.1.1 Americas Chronic Urticaria Medicine Sales by Country (2021-2026)
5.1.2 Americas Chronic Urticaria Medicine Revenue by Country (2021-2026)
5.2 Americas Chronic Urticaria Medicine Sales by Type (2021-2026)
5.3 Americas Chronic Urticaria Medicine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Urticaria Medicine Sales by Region
6.1.1 APAC Chronic Urticaria Medicine Sales by Region (2021-2026)
6.1.2 APAC Chronic Urticaria Medicine Revenue by Region (2021-2026)
6.2 APAC Chronic Urticaria Medicine Sales by Type (2021-2026)
6.3 APAC Chronic Urticaria Medicine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Urticaria Medicine by Country
7.1.1 Europe Chronic Urticaria Medicine Sales by Country (2021-2026)
7.1.2 Europe Chronic Urticaria Medicine Revenue by Country (2021-2026)
7.2 Europe Chronic Urticaria Medicine Sales by Type (2021-2026)
7.3 Europe Chronic Urticaria Medicine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Urticaria Medicine by Country
8.1.1 Middle East & Africa Chronic Urticaria Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Chronic Urticaria Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Chronic Urticaria Medicine Sales by Type (2021-2026)
8.3 Middle East & Africa Chronic Urticaria Medicine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Urticaria Medicine
10.3 Manufacturing Process Analysis of Chronic Urticaria Medicine
10.4 Industry Chain Structure of Chronic Urticaria Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Urticaria Medicine Distributors
11.3 Chronic Urticaria Medicine Customer
12 WORLD FORECAST REVIEW FOR CHRONIC URTICARIA MEDICINE BY GEOGRAPHIC REGION
12.1 Global Chronic Urticaria Medicine Market Size Forecast by Region
12.1.1 Global Chronic Urticaria Medicine Forecast by Region (2027-2032)
12.1.2 Global Chronic Urticaria Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Chronic Urticaria Medicine Forecast by Type (2027-2032)
12.7 Global Chronic Urticaria Medicine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Chronic Urticaria Medicine Product Portfolios and Specifications
13.1.3 Johnson & Johnson Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Chronic Urticaria Medicine Product Portfolios and Specifications
13.2.3 Merck Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Fresenius
13.3.1 Fresenius Company Information
13.3.2 Fresenius Chronic Urticaria Medicine Product Portfolios and Specifications
13.3.3 Fresenius Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fresenius Main Business Overview
13.3.5 Fresenius Latest Developments
13.4 3SBIO
13.4.1 3SBIO Company Information
13.4.2 3SBIO Chronic Urticaria Medicine Product Portfolios and Specifications
13.4.3 3SBIO Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 3SBIO Main Business Overview
13.4.5 3SBIO Latest Developments
13.5 SPHBIO
13.5.1 SPHBIO Company Information
13.5.2 SPHBIO Chronic Urticaria Medicine Product Portfolios and Specifications
13.5.3 SPHBIO Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 SPHBIO Main Business Overview
13.5.5 SPHBIO Latest Developments
13.6 Sun Pharmaceutical Industries
13.6.1 Sun Pharmaceutical Industries Company Information
13.6.2 Sun Pharmaceutical Industries Chronic Urticaria Medicine Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharmaceutical Industries Main Business Overview
13.6.5 Sun Pharmaceutical Industries Latest Developments
13.7 Yangtze River Pharmaceutical Group
13.7.1 Yangtze River Pharmaceutical Group Company Information
13.7.2 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
13.7.3 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Yangtze River Pharmaceutical Group Main Business Overview
13.7.5 Yangtze River Pharmaceutical Group Latest Developments
13.8 CSPC Pharmaceutical Group
13.8.1 CSPC Pharmaceutical Group Company Information
13.8.2 CSPC Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
13.8.3 CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 CSPC Pharmaceutical Group Main Business Overview
13.8.5 CSPC Pharmaceutical Group Latest Developments
13.9 Shanxi C&Y Pharmaceutical Group
13.9.1 Shanxi C&Y Pharmaceutical Group Company Information
13.9.2 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
13.9.3 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Shanxi C&Y Pharmaceutical Group Main Business Overview
13.9.5 Shanxi C&Y Pharmaceutical Group Latest Developments
13.10 Lianhuan Pharma
13.10.1 Lianhuan Pharma Company Information
13.10.2 Lianhuan Pharma Chronic Urticaria Medicine Product Portfolios and Specifications
13.10.3 Lianhuan Pharma Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lianhuan Pharma Main Business Overview
13.10.5 Lianhuan Pharma Latest Developments
13.11 Jiudian Pharmaceutical
13.11.1 Jiudian Pharmaceutical Company Information
13.11.2 Jiudian Pharmaceutical Chronic Urticaria Medicine Product Portfolios and Specifications
13.11.3 Jiudian Pharmaceutical Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiudian Pharmaceutical Main Business Overview
13.11.5 Jiudian Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Urticaria Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Chronic Urticaria Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Chronic Urticaria Medicine by Country/Region, 2021, 2025 & 2032
2.2 Chronic Urticaria Medicine Segment by Type
2.2.1 Loratadine
2.2.2 Desloratadine
2.2.3 Fexofenadine
2.2.4 Ebastine
2.2.5 Stastine
2.2.6 Cetirizine
2.2.7 Levocetirizine
2.2.8 Cinnarizine
2.2.9 Other
2.2.10 Chronic Urticaria Medicine Sales by Type
2.2.10.1 Global Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
2.2.10.2 Global Chronic Urticaria Medicine Revenue and Market Share by Type (2021-2026)
2.2.10.3 Global Chronic Urticaria Medicine Sale Price by Type (2021-2026)
2.3 Chronic Urticaria Medicine Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Specialist Medical Centre
2.3.3 Retail Pharmacies
2.3.4 Other
2.3.5 Chronic Urticaria Medicine Sales by Application
2.3.5.1 Global Chronic Urticaria Medicine Sale Market Share by Application (2021-2026)
2.3.5.2 Global Chronic Urticaria Medicine Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Chronic Urticaria Medicine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Chronic Urticaria Medicine Breakdown Data by Company
3.1.1 Global Chronic Urticaria Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Chronic Urticaria Medicine Sales Market Share by Company (2021-2026)
3.2 Global Chronic Urticaria Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Chronic Urticaria Medicine Revenue by Company (2021-2026)
3.2.2 Global Chronic Urticaria Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Chronic Urticaria Medicine Sale Price by Company
3.4 Key Manufacturers Chronic Urticaria Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Urticaria Medicine Product Location Distribution
3.4.2 Players Chronic Urticaria Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHRONIC URTICARIA MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Chronic Urticaria Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Chronic Urticaria Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Chronic Urticaria Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Chronic Urticaria Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Chronic Urticaria Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Chronic Urticaria Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Chronic Urticaria Medicine Sales Growth
4.4 APAC Chronic Urticaria Medicine Sales Growth
4.5 Europe Chronic Urticaria Medicine Sales Growth
4.6 Middle East & Africa Chronic Urticaria Medicine Sales Growth
5 AMERICAS
5.1 Americas Chronic Urticaria Medicine Sales by Country
5.1.1 Americas Chronic Urticaria Medicine Sales by Country (2021-2026)
5.1.2 Americas Chronic Urticaria Medicine Revenue by Country (2021-2026)
5.2 Americas Chronic Urticaria Medicine Sales by Type (2021-2026)
5.3 Americas Chronic Urticaria Medicine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Urticaria Medicine Sales by Region
6.1.1 APAC Chronic Urticaria Medicine Sales by Region (2021-2026)
6.1.2 APAC Chronic Urticaria Medicine Revenue by Region (2021-2026)
6.2 APAC Chronic Urticaria Medicine Sales by Type (2021-2026)
6.3 APAC Chronic Urticaria Medicine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Urticaria Medicine by Country
7.1.1 Europe Chronic Urticaria Medicine Sales by Country (2021-2026)
7.1.2 Europe Chronic Urticaria Medicine Revenue by Country (2021-2026)
7.2 Europe Chronic Urticaria Medicine Sales by Type (2021-2026)
7.3 Europe Chronic Urticaria Medicine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Urticaria Medicine by Country
8.1.1 Middle East & Africa Chronic Urticaria Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Chronic Urticaria Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Chronic Urticaria Medicine Sales by Type (2021-2026)
8.3 Middle East & Africa Chronic Urticaria Medicine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Urticaria Medicine
10.3 Manufacturing Process Analysis of Chronic Urticaria Medicine
10.4 Industry Chain Structure of Chronic Urticaria Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Urticaria Medicine Distributors
11.3 Chronic Urticaria Medicine Customer
12 WORLD FORECAST REVIEW FOR CHRONIC URTICARIA MEDICINE BY GEOGRAPHIC REGION
12.1 Global Chronic Urticaria Medicine Market Size Forecast by Region
12.1.1 Global Chronic Urticaria Medicine Forecast by Region (2027-2032)
12.1.2 Global Chronic Urticaria Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Chronic Urticaria Medicine Forecast by Type (2027-2032)
12.7 Global Chronic Urticaria Medicine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Chronic Urticaria Medicine Product Portfolios and Specifications
13.1.3 Johnson & Johnson Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Chronic Urticaria Medicine Product Portfolios and Specifications
13.2.3 Merck Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Fresenius
13.3.1 Fresenius Company Information
13.3.2 Fresenius Chronic Urticaria Medicine Product Portfolios and Specifications
13.3.3 Fresenius Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fresenius Main Business Overview
13.3.5 Fresenius Latest Developments
13.4 3SBIO
13.4.1 3SBIO Company Information
13.4.2 3SBIO Chronic Urticaria Medicine Product Portfolios and Specifications
13.4.3 3SBIO Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 3SBIO Main Business Overview
13.4.5 3SBIO Latest Developments
13.5 SPHBIO
13.5.1 SPHBIO Company Information
13.5.2 SPHBIO Chronic Urticaria Medicine Product Portfolios and Specifications
13.5.3 SPHBIO Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 SPHBIO Main Business Overview
13.5.5 SPHBIO Latest Developments
13.6 Sun Pharmaceutical Industries
13.6.1 Sun Pharmaceutical Industries Company Information
13.6.2 Sun Pharmaceutical Industries Chronic Urticaria Medicine Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharmaceutical Industries Main Business Overview
13.6.5 Sun Pharmaceutical Industries Latest Developments
13.7 Yangtze River Pharmaceutical Group
13.7.1 Yangtze River Pharmaceutical Group Company Information
13.7.2 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
13.7.3 Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Yangtze River Pharmaceutical Group Main Business Overview
13.7.5 Yangtze River Pharmaceutical Group Latest Developments
13.8 CSPC Pharmaceutical Group
13.8.1 CSPC Pharmaceutical Group Company Information
13.8.2 CSPC Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
13.8.3 CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 CSPC Pharmaceutical Group Main Business Overview
13.8.5 CSPC Pharmaceutical Group Latest Developments
13.9 Shanxi C&Y Pharmaceutical Group
13.9.1 Shanxi C&Y Pharmaceutical Group Company Information
13.9.2 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
13.9.3 Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Shanxi C&Y Pharmaceutical Group Main Business Overview
13.9.5 Shanxi C&Y Pharmaceutical Group Latest Developments
13.10 Lianhuan Pharma
13.10.1 Lianhuan Pharma Company Information
13.10.2 Lianhuan Pharma Chronic Urticaria Medicine Product Portfolios and Specifications
13.10.3 Lianhuan Pharma Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lianhuan Pharma Main Business Overview
13.10.5 Lianhuan Pharma Latest Developments
13.11 Jiudian Pharmaceutical
13.11.1 Jiudian Pharmaceutical Company Information
13.11.2 Jiudian Pharmaceutical Chronic Urticaria Medicine Product Portfolios and Specifications
13.11.3 Jiudian Pharmaceutical Chronic Urticaria Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiudian Pharmaceutical Main Business Overview
13.11.5 Jiudian Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chronic Urticaria Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Chronic Urticaria Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Loratadine
Table 4. Major Players of Desloratadine
Table 5. Major Players of Fexofenadine
Table 6. Major Players of Ebastine
Table 7. Major Players of Stastine
Table 8. Major Players of Cetirizine
Table 9. Major Players of Levocetirizine
Table 10. Major Players of Cinnarizine
Table 11. Major Players of Other
Table 12. Global Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 13. Global Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Table 14. Global Chronic Urticaria Medicine Revenue by Type (2021-2026) & ($ million)
Table 15. Global Chronic Urticaria Medicine Revenue Market Share by Type (2021-2026)
Table 16. Global Chronic Urticaria Medicine Sale Price by Type (2021-2026) & (US$/Unit)
Table 17. Global Chronic Urticaria Medicine Sale by Application (2021-2026) & (K Units)
Table 18. Global Chronic Urticaria Medicine Sale Market Share by Application (2021-2026)
Table 19. Global Chronic Urticaria Medicine Revenue by Application (2021-2026) & ($ million)
Table 20. Global Chronic Urticaria Medicine Revenue Market Share by Application (2021-2026)
Table 21. Global Chronic Urticaria Medicine Sale Price by Application (2021-2026) & (US$/Unit)
Table 22. Global Chronic Urticaria Medicine Sales by Company (2021-2026) & (K Units)
Table 23. Global Chronic Urticaria Medicine Sales Market Share by Company (2021-2026)
Table 24. Global Chronic Urticaria Medicine Revenue by Company (2021-2026) & ($ millions)
Table 25. Global Chronic Urticaria Medicine Revenue Market Share by Company (2021-2026)
Table 26. Global Chronic Urticaria Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 27. Key Manufacturers Chronic Urticaria Medicine Producing Area Distribution and Sales Area
Table 28. Players Chronic Urticaria Medicine Products Offered
Table 29. Chronic Urticaria Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Market M&A Activity & Strategy
Table 32. Global Chronic Urticaria Medicine Sales by Geographic Region (2021-2026) & (K Units)
Table 33. Global Chronic Urticaria Medicine Sales Market Share Geographic Region (2021-2026)
Table 34. Global Chronic Urticaria Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 35. Global Chronic Urticaria Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 36. Global Chronic Urticaria Medicine Sales by Country/Region (2021-2026) & (K Units)
Table 37. Global Chronic Urticaria Medicine Sales Market Share by Country/Region (2021-2026)
Table 38. Global Chronic Urticaria Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 39. Global Chronic Urticaria Medicine Revenue Market Share by Country/Region (2021-2026)
Table 40. Americas Chronic Urticaria Medicine Sales by Country (2021-2026) & (K Units)
Table 41. Americas Chronic Urticaria Medicine Sales Market Share by Country (2021-2026)
Table 42. Americas Chronic Urticaria Medicine Revenue by Country (2021-2026) & ($ millions)
Table 43. Americas Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 44. Americas Chronic Urticaria Medicine Sales by Application (2021-2026) & (K Units)
Table 45. APAC Chronic Urticaria Medicine Sales by Region (2021-2026) & (K Units)
Table 46. APAC Chronic Urticaria Medicine Sales Market Share by Region (2021-2026)
Table 47. APAC Chronic Urticaria Medicine Revenue by Region (2021-2026) & ($ millions)
Table 48. APAC Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 49. APAC Chronic Urticaria Medicine Sales by Application (2021-2026) & (K Units)
Table 50. Europe Chronic Urticaria Medicine Sales by Country (2021-2026) & (K Units)
Table 51. Europe Chronic Urticaria Medicine Revenue by Country (2021-2026) & ($ millions)
Table 52. Europe Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 53. Europe Chronic Urticaria Medicine Sales by Application (2021-2026) & (K Units)
Table 54. Middle East & Africa Chronic Urticaria Medicine Sales by Country (2021-2026) & (K Units)
Table 55. Middle East & Africa Chronic Urticaria Medicine Revenue Market Share by Country (2021-2026)
Table 56. Middle East & Africa Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 57. Middle East & Africa Chronic Urticaria Medicine Sales by Application (2021-2026) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Chronic Urticaria Medicine
Table 59. Key Market Challenges & Risks of Chronic Urticaria Medicine
Table 60. Key Industry Trends of Chronic Urticaria Medicine
Table 61. Chronic Urticaria Medicine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Chronic Urticaria Medicine Distributors List
Table 64. Chronic Urticaria Medicine Customer List
Table 65. Global Chronic Urticaria Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 66. Global Chronic Urticaria Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Americas Chronic Urticaria Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Americas Chronic Urticaria Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. APAC Chronic Urticaria Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 70. APAC Chronic Urticaria Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Europe Chronic Urticaria Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 72. Europe Chronic Urticaria Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. Middle East & Africa Chronic Urticaria Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Middle East & Africa Chronic Urticaria Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Global Chronic Urticaria Medicine Sales Forecast by Type (2027-2032) & (K Units)
Table 76. Global Chronic Urticaria Medicine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 77. Global Chronic Urticaria Medicine Sales Forecast by Application (2027-2032) & (K Units)
Table 78. Global Chronic Urticaria Medicine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 79. Johnson & Johnson Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson & Johnson Chronic Urticaria Medicine Product Portfolios and Specifications
Table 81. Johnson & Johnson Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. Merck Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Chronic Urticaria Medicine Product Portfolios and Specifications
Table 86. Merck Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Fresenius Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. Fresenius Chronic Urticaria Medicine Product Portfolios and Specifications
Table 91. Fresenius Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Fresenius Main Business
Table 93. Fresenius Latest Developments
Table 94. 3SBIO Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. 3SBIO Chronic Urticaria Medicine Product Portfolios and Specifications
Table 96. 3SBIO Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. 3SBIO Main Business
Table 98. 3SBIO Latest Developments
Table 99. SPHBIO Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. SPHBIO Chronic Urticaria Medicine Product Portfolios and Specifications
Table 101. SPHBIO Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. SPHBIO Main Business
Table 103. SPHBIO Latest Developments
Table 104. Sun Pharmaceutical Industries Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. Sun Pharmaceutical Industries Chronic Urticaria Medicine Product Portfolios and Specifications
Table 106. Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Sun Pharmaceutical Industries Main Business
Table 108. Sun Pharmaceutical Industries Latest Developments
Table 109. Yangtze River Pharmaceutical Group Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
Table 111. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Yangtze River Pharmaceutical Group Main Business
Table 113. Yangtze River Pharmaceutical Group Latest Developments
Table 114. CSPC Pharmaceutical Group Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. CSPC Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
Table 116. CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. CSPC Pharmaceutical Group Main Business
Table 118. CSPC Pharmaceutical Group Latest Developments
Table 119. Shanxi C&Y Pharmaceutical Group Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
Table 121. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Shanxi C&Y Pharmaceutical Group Main Business
Table 123. Shanxi C&Y Pharmaceutical Group Latest Developments
Table 124. Lianhuan Pharma Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. Lianhuan Pharma Chronic Urticaria Medicine Product Portfolios and Specifications
Table 126. Lianhuan Pharma Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Lianhuan Pharma Main Business
Table 128. Lianhuan Pharma Latest Developments
Table 129. Jiudian Pharmaceutical Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 130. Jiudian Pharmaceutical Chronic Urticaria Medicine Product Portfolios and Specifications
Table 131. Jiudian Pharmaceutical Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Jiudian Pharmaceutical Main Business
Table 133. Jiudian Pharmaceutical Latest Developments
Table 1. Chronic Urticaria Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Chronic Urticaria Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Loratadine
Table 4. Major Players of Desloratadine
Table 5. Major Players of Fexofenadine
Table 6. Major Players of Ebastine
Table 7. Major Players of Stastine
Table 8. Major Players of Cetirizine
Table 9. Major Players of Levocetirizine
Table 10. Major Players of Cinnarizine
Table 11. Major Players of Other
Table 12. Global Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 13. Global Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Table 14. Global Chronic Urticaria Medicine Revenue by Type (2021-2026) & ($ million)
Table 15. Global Chronic Urticaria Medicine Revenue Market Share by Type (2021-2026)
Table 16. Global Chronic Urticaria Medicine Sale Price by Type (2021-2026) & (US$/Unit)
Table 17. Global Chronic Urticaria Medicine Sale by Application (2021-2026) & (K Units)
Table 18. Global Chronic Urticaria Medicine Sale Market Share by Application (2021-2026)
Table 19. Global Chronic Urticaria Medicine Revenue by Application (2021-2026) & ($ million)
Table 20. Global Chronic Urticaria Medicine Revenue Market Share by Application (2021-2026)
Table 21. Global Chronic Urticaria Medicine Sale Price by Application (2021-2026) & (US$/Unit)
Table 22. Global Chronic Urticaria Medicine Sales by Company (2021-2026) & (K Units)
Table 23. Global Chronic Urticaria Medicine Sales Market Share by Company (2021-2026)
Table 24. Global Chronic Urticaria Medicine Revenue by Company (2021-2026) & ($ millions)
Table 25. Global Chronic Urticaria Medicine Revenue Market Share by Company (2021-2026)
Table 26. Global Chronic Urticaria Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 27. Key Manufacturers Chronic Urticaria Medicine Producing Area Distribution and Sales Area
Table 28. Players Chronic Urticaria Medicine Products Offered
Table 29. Chronic Urticaria Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Market M&A Activity & Strategy
Table 32. Global Chronic Urticaria Medicine Sales by Geographic Region (2021-2026) & (K Units)
Table 33. Global Chronic Urticaria Medicine Sales Market Share Geographic Region (2021-2026)
Table 34. Global Chronic Urticaria Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 35. Global Chronic Urticaria Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 36. Global Chronic Urticaria Medicine Sales by Country/Region (2021-2026) & (K Units)
Table 37. Global Chronic Urticaria Medicine Sales Market Share by Country/Region (2021-2026)
Table 38. Global Chronic Urticaria Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 39. Global Chronic Urticaria Medicine Revenue Market Share by Country/Region (2021-2026)
Table 40. Americas Chronic Urticaria Medicine Sales by Country (2021-2026) & (K Units)
Table 41. Americas Chronic Urticaria Medicine Sales Market Share by Country (2021-2026)
Table 42. Americas Chronic Urticaria Medicine Revenue by Country (2021-2026) & ($ millions)
Table 43. Americas Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 44. Americas Chronic Urticaria Medicine Sales by Application (2021-2026) & (K Units)
Table 45. APAC Chronic Urticaria Medicine Sales by Region (2021-2026) & (K Units)
Table 46. APAC Chronic Urticaria Medicine Sales Market Share by Region (2021-2026)
Table 47. APAC Chronic Urticaria Medicine Revenue by Region (2021-2026) & ($ millions)
Table 48. APAC Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 49. APAC Chronic Urticaria Medicine Sales by Application (2021-2026) & (K Units)
Table 50. Europe Chronic Urticaria Medicine Sales by Country (2021-2026) & (K Units)
Table 51. Europe Chronic Urticaria Medicine Revenue by Country (2021-2026) & ($ millions)
Table 52. Europe Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 53. Europe Chronic Urticaria Medicine Sales by Application (2021-2026) & (K Units)
Table 54. Middle East & Africa Chronic Urticaria Medicine Sales by Country (2021-2026) & (K Units)
Table 55. Middle East & Africa Chronic Urticaria Medicine Revenue Market Share by Country (2021-2026)
Table 56. Middle East & Africa Chronic Urticaria Medicine Sales by Type (2021-2026) & (K Units)
Table 57. Middle East & Africa Chronic Urticaria Medicine Sales by Application (2021-2026) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Chronic Urticaria Medicine
Table 59. Key Market Challenges & Risks of Chronic Urticaria Medicine
Table 60. Key Industry Trends of Chronic Urticaria Medicine
Table 61. Chronic Urticaria Medicine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Chronic Urticaria Medicine Distributors List
Table 64. Chronic Urticaria Medicine Customer List
Table 65. Global Chronic Urticaria Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 66. Global Chronic Urticaria Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Americas Chronic Urticaria Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Americas Chronic Urticaria Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. APAC Chronic Urticaria Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 70. APAC Chronic Urticaria Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Europe Chronic Urticaria Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 72. Europe Chronic Urticaria Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. Middle East & Africa Chronic Urticaria Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Middle East & Africa Chronic Urticaria Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Global Chronic Urticaria Medicine Sales Forecast by Type (2027-2032) & (K Units)
Table 76. Global Chronic Urticaria Medicine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 77. Global Chronic Urticaria Medicine Sales Forecast by Application (2027-2032) & (K Units)
Table 78. Global Chronic Urticaria Medicine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 79. Johnson & Johnson Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson & Johnson Chronic Urticaria Medicine Product Portfolios and Specifications
Table 81. Johnson & Johnson Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. Merck Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Chronic Urticaria Medicine Product Portfolios and Specifications
Table 86. Merck Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Fresenius Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. Fresenius Chronic Urticaria Medicine Product Portfolios and Specifications
Table 91. Fresenius Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Fresenius Main Business
Table 93. Fresenius Latest Developments
Table 94. 3SBIO Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. 3SBIO Chronic Urticaria Medicine Product Portfolios and Specifications
Table 96. 3SBIO Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. 3SBIO Main Business
Table 98. 3SBIO Latest Developments
Table 99. SPHBIO Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. SPHBIO Chronic Urticaria Medicine Product Portfolios and Specifications
Table 101. SPHBIO Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. SPHBIO Main Business
Table 103. SPHBIO Latest Developments
Table 104. Sun Pharmaceutical Industries Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. Sun Pharmaceutical Industries Chronic Urticaria Medicine Product Portfolios and Specifications
Table 106. Sun Pharmaceutical Industries Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Sun Pharmaceutical Industries Main Business
Table 108. Sun Pharmaceutical Industries Latest Developments
Table 109. Yangtze River Pharmaceutical Group Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
Table 111. Yangtze River Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Yangtze River Pharmaceutical Group Main Business
Table 113. Yangtze River Pharmaceutical Group Latest Developments
Table 114. CSPC Pharmaceutical Group Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. CSPC Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
Table 116. CSPC Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. CSPC Pharmaceutical Group Main Business
Table 118. CSPC Pharmaceutical Group Latest Developments
Table 119. Shanxi C&Y Pharmaceutical Group Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Product Portfolios and Specifications
Table 121. Shanxi C&Y Pharmaceutical Group Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Shanxi C&Y Pharmaceutical Group Main Business
Table 123. Shanxi C&Y Pharmaceutical Group Latest Developments
Table 124. Lianhuan Pharma Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. Lianhuan Pharma Chronic Urticaria Medicine Product Portfolios and Specifications
Table 126. Lianhuan Pharma Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Lianhuan Pharma Main Business
Table 128. Lianhuan Pharma Latest Developments
Table 129. Jiudian Pharmaceutical Basic Information, Chronic Urticaria Medicine Manufacturing Base, Sales Area and Its Competitors
Table 130. Jiudian Pharmaceutical Chronic Urticaria Medicine Product Portfolios and Specifications
Table 131. Jiudian Pharmaceutical Chronic Urticaria Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Jiudian Pharmaceutical Main Business
Table 133. Jiudian Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Chronic Urticaria Medicine
Figure 2. Chronic Urticaria Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Urticaria Medicine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Chronic Urticaria Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Chronic Urticaria Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Chronic Urticaria Medicine Sales Market Share by Country/Region (2025)
Figure 10. Chronic Urticaria Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Loratadine
Figure 12. Product Picture of Desloratadine
Figure 13. Product Picture of Fexofenadine
Figure 14. Product Picture of Ebastine
Figure 15. Product Picture of Stastine
Figure 16. Product Picture of Cetirizine
Figure 17. Product Picture of Levocetirizine
Figure 18. Product Picture of Cinnarizine
Figure 19. Product Picture of Other
Figure 20. Global Chronic Urticaria Medicine Sales Market Share by Type in 2026
Figure 21. Global Chronic Urticaria Medicine Revenue Market Share by Type (2021-2026)
Figure 22. Chronic Urticaria Medicine Consumed in Hospital and Clinic
Figure 23. Global Chronic Urticaria Medicine Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 24. Chronic Urticaria Medicine Consumed in Specialist Medical Centre
Figure 25. Global Chronic Urticaria Medicine Market: Specialist Medical Centre (2021-2026) & (K Units)
Figure 26. Chronic Urticaria Medicine Consumed in Retail Pharmacies
Figure 27. Global Chronic Urticaria Medicine Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 28. Chronic Urticaria Medicine Consumed in Other
Figure 29. Global Chronic Urticaria Medicine Market: Other (2021-2026) & (K Units)
Figure 30. Global Chronic Urticaria Medicine Sale Market Share by Application (2025)
Figure 31. Global Chronic Urticaria Medicine Revenue Market Share by Application in 2026
Figure 32. Chronic Urticaria Medicine Sales by Company in 2026 (K Units)
Figure 33. Global Chronic Urticaria Medicine Sales Market Share by Company in 2026
Figure 34. Chronic Urticaria Medicine Revenue by Company in 2026 ($ millions)
Figure 35. Global Chronic Urticaria Medicine Revenue Market Share by Company in 2026
Figure 36. Global Chronic Urticaria Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Chronic Urticaria Medicine Revenue Market Share by Geographic Region in 2026
Figure 38. Americas Chronic Urticaria Medicine Sales 2021-2026 (K Units)
Figure 39. Americas Chronic Urticaria Medicine Revenue 2021-2026 ($ millions)
Figure 40. APAC Chronic Urticaria Medicine Sales 2021-2026 (K Units)
Figure 41. APAC Chronic Urticaria Medicine Revenue 2021-2026 ($ millions)
Figure 42. Europe Chronic Urticaria Medicine Sales 2021-2026 (K Units)
Figure 43. Europe Chronic Urticaria Medicine Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Chronic Urticaria Medicine Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Chronic Urticaria Medicine Revenue 2021-2026 ($ millions)
Figure 46. Americas Chronic Urticaria Medicine Sales Market Share by Country in 2026
Figure 47. Americas Chronic Urticaria Medicine Revenue Market Share by Country (2021-2026)
Figure 48. Americas Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Figure 49. Americas Chronic Urticaria Medicine Sales Market Share by Application (2021-2026)
Figure 50. United States Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Chronic Urticaria Medicine Sales Market Share by Region in 2026
Figure 55. APAC Chronic Urticaria Medicine Revenue Market Share by Region (2021-2026)
Figure 56. APAC Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Figure 57. APAC Chronic Urticaria Medicine Sales Market Share by Application (2021-2026)
Figure 58. China Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 62. India Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Chronic Urticaria Medicine Sales Market Share by Country in 2026
Figure 66. Europe Chronic Urticaria Medicine Revenue Market Share by Country (2021-2026)
Figure 67. Europe Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Figure 68. Europe Chronic Urticaria Medicine Sales Market Share by Application (2021-2026)
Figure 69. Germany Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 70. France Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Chronic Urticaria Medicine Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Chronic Urticaria Medicine Sales Market Share by Application (2021-2026)
Figure 77. Egypt Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Chronic Urticaria Medicine in 2026
Figure 83. Manufacturing Process Analysis of Chronic Urticaria Medicine
Figure 84. Industry Chain Structure of Chronic Urticaria Medicine
Figure 85. Channels of Distribution
Figure 86. Global Chronic Urticaria Medicine Sales Market Forecast by Region (2027-2032)
Figure 87. Global Chronic Urticaria Medicine Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Chronic Urticaria Medicine Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Chronic Urticaria Medicine Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Chronic Urticaria Medicine Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Chronic Urticaria Medicine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Chronic Urticaria Medicine
Figure 2. Chronic Urticaria Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Urticaria Medicine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Chronic Urticaria Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Chronic Urticaria Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Chronic Urticaria Medicine Sales Market Share by Country/Region (2025)
Figure 10. Chronic Urticaria Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Loratadine
Figure 12. Product Picture of Desloratadine
Figure 13. Product Picture of Fexofenadine
Figure 14. Product Picture of Ebastine
Figure 15. Product Picture of Stastine
Figure 16. Product Picture of Cetirizine
Figure 17. Product Picture of Levocetirizine
Figure 18. Product Picture of Cinnarizine
Figure 19. Product Picture of Other
Figure 20. Global Chronic Urticaria Medicine Sales Market Share by Type in 2026
Figure 21. Global Chronic Urticaria Medicine Revenue Market Share by Type (2021-2026)
Figure 22. Chronic Urticaria Medicine Consumed in Hospital and Clinic
Figure 23. Global Chronic Urticaria Medicine Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 24. Chronic Urticaria Medicine Consumed in Specialist Medical Centre
Figure 25. Global Chronic Urticaria Medicine Market: Specialist Medical Centre (2021-2026) & (K Units)
Figure 26. Chronic Urticaria Medicine Consumed in Retail Pharmacies
Figure 27. Global Chronic Urticaria Medicine Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 28. Chronic Urticaria Medicine Consumed in Other
Figure 29. Global Chronic Urticaria Medicine Market: Other (2021-2026) & (K Units)
Figure 30. Global Chronic Urticaria Medicine Sale Market Share by Application (2025)
Figure 31. Global Chronic Urticaria Medicine Revenue Market Share by Application in 2026
Figure 32. Chronic Urticaria Medicine Sales by Company in 2026 (K Units)
Figure 33. Global Chronic Urticaria Medicine Sales Market Share by Company in 2026
Figure 34. Chronic Urticaria Medicine Revenue by Company in 2026 ($ millions)
Figure 35. Global Chronic Urticaria Medicine Revenue Market Share by Company in 2026
Figure 36. Global Chronic Urticaria Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Chronic Urticaria Medicine Revenue Market Share by Geographic Region in 2026
Figure 38. Americas Chronic Urticaria Medicine Sales 2021-2026 (K Units)
Figure 39. Americas Chronic Urticaria Medicine Revenue 2021-2026 ($ millions)
Figure 40. APAC Chronic Urticaria Medicine Sales 2021-2026 (K Units)
Figure 41. APAC Chronic Urticaria Medicine Revenue 2021-2026 ($ millions)
Figure 42. Europe Chronic Urticaria Medicine Sales 2021-2026 (K Units)
Figure 43. Europe Chronic Urticaria Medicine Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Chronic Urticaria Medicine Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Chronic Urticaria Medicine Revenue 2021-2026 ($ millions)
Figure 46. Americas Chronic Urticaria Medicine Sales Market Share by Country in 2026
Figure 47. Americas Chronic Urticaria Medicine Revenue Market Share by Country (2021-2026)
Figure 48. Americas Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Figure 49. Americas Chronic Urticaria Medicine Sales Market Share by Application (2021-2026)
Figure 50. United States Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Chronic Urticaria Medicine Sales Market Share by Region in 2026
Figure 55. APAC Chronic Urticaria Medicine Revenue Market Share by Region (2021-2026)
Figure 56. APAC Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Figure 57. APAC Chronic Urticaria Medicine Sales Market Share by Application (2021-2026)
Figure 58. China Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 62. India Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Chronic Urticaria Medicine Sales Market Share by Country in 2026
Figure 66. Europe Chronic Urticaria Medicine Revenue Market Share by Country (2021-2026)
Figure 67. Europe Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Figure 68. Europe Chronic Urticaria Medicine Sales Market Share by Application (2021-2026)
Figure 69. Germany Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 70. France Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Chronic Urticaria Medicine Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Chronic Urticaria Medicine Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Chronic Urticaria Medicine Sales Market Share by Application (2021-2026)
Figure 77. Egypt Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Chronic Urticaria Medicine Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Chronic Urticaria Medicine in 2026
Figure 83. Manufacturing Process Analysis of Chronic Urticaria Medicine
Figure 84. Industry Chain Structure of Chronic Urticaria Medicine
Figure 85. Channels of Distribution
Figure 86. Global Chronic Urticaria Medicine Sales Market Forecast by Region (2027-2032)
Figure 87. Global Chronic Urticaria Medicine Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Chronic Urticaria Medicine Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Chronic Urticaria Medicine Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Chronic Urticaria Medicine Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Chronic Urticaria Medicine Revenue Market Share Forecast by Application (2027-2032)
